Anna Santoro | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Book of Award

Dr. Anna Santoro | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Beth Israel Deaconess Medical Center | United States

Dr. Anna Santoro’s research profile reflects a strong and sustained contribution to biomedical and toxicological sciences, with a particular focus on inflammatory pathways, metabolic regulation, environmental toxicants, and neuroendocrine mechanisms. Her scholarly output comprises 28 peer-reviewed documents, which together have received 1,584 citations across 1,472 citing documents, demonstrating broad international impact and cross-disciplinary relevance. With an h-index of 22, her work shows both productivity and consistent citation performance. Key investigations explore the biological effects of non-dioxin-like polychlorinated biphenyls on cellular apoptosis, lipid metabolism, and endocrine signaling, alongside influential studies on palmitoylethanolamide and its protective roles in metabolic disorders, hypertension, renal injury, and neuroinflammation. Her publications in high-impact journals such as Toxicology Letters, Endocrinology, PLoS One, and Journal of Nutritional Biochemistry highlight rigorous experimental approaches and translational relevance, positioning her research as a significant reference point in toxicology, pharmacology, and metabolic disease research.

Citation Metrics (Scopus)

1600

1200

800

400

0

Citations
1,584

h-index
22

Citations

h-index


View Scopus Profile

Featured Publications

Elena Cantone | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Prof. Dr. Elena Cantone | Medicine and Dentistry | Research Excellence Award

University of Calabria | Italy

Prof. Dr. Elena Cantone is a highly accomplished researcher in the field of otorhinolaryngology, with a strong and sustained impact on clinical and translational research. Her scholarly output comprises 126 peer-reviewed documents, which together have received 1,953 citations from 1,649 citing documents, reflecting wide international recognition of her work. She maintains an h-index of 25, underscoring both the productivity and consistent influence of her research contributions. Her publications address key topics in chronic rhinosinusitis with nasal polyps (CRSwNP), severe asthma comorbidities, cystic fibrosis–related ENT manifestations, nasal cytology, biologic therapies, and multidisciplinary management strategies. She has played a significant role in advancing real-world evidence on biologic treatments such as dupilumab and mepolizumab, contributing to clinical guidelines, composite severity scoring systems, and long-term outcome assessments. Her research is frequently published in high-impact international journals including Allergy, Clinical Otolaryngology, Journal of Clinical Medicine, Journal of Cystic Fibrosis, The Laryngoscope, and Current Allergy and Asthma Reports. Through collaborative, multicenter studies and clinically driven investigations, her work continues to shape evidence-based practice and improve understanding of inflammatory and airway diseases at both national and international levels.

 

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1,953

h-index
25

Documents
126

Citations

h-index

Documents


View Scopus Profile

Featured Publications

Yizhao Li | Engineering | Research Excellence Award

Published on by Book of Award

Ms. Yizhao Li | Engineering | Research Excellence Award

Shanghai University | China

Yizhao Li is a researcher specializing in biomechanics, biomedical instrumentation, and implant-related mechanics, with a research portfolio spanning orthopaedic implants, biofidelic physical models, and advanced sensing technologies. The research work focuses on in vitro wear testing of ankle prostheses, energy harvesting sensor packages for knee implants, knee joint contact mechanics related to meniscus root tears, and cadaver-based experimental validation of implant performance and durability. Earlier research contributions include the development of biofidelic instrumented headforms for head injury biomechanics, miniature optical fiber sensors for rapid intracranial pressure measurement, and image-based analysis of fuel–air explosive cloud growth. The research demonstrates strong integration of experimental mechanics, structural design, simulation, sensing, and measurement, with applications in injury biomechanics, orthopaedic engineering, and safety device evaluation. The scholarly output comprises peer-reviewed journal articles published in leading journals such as Journal of Biomechanics, Annals of Biomedical Engineering, Journal of Mechanical Behavior of Biomedical Materials, Journal of Biomechanical Engineering, and IEEE Transactions on Instrumentation and Measurement, along with multiple international conference publications. According to Google Scholar metrics, the research has received 84 citations, with an h-index of 5 and an i10-index of 3, reflecting growing impact and consistent contributions to biomechanics, biomedical engineering, and measurement science.

 

Citation Metrics (Google Scholar)

10080

60

40

20

0

Citations
84

h-index
5

i10-index
3

Citations

h-index

i10-index


View Google Scholar Profile

Featured Publications

Offline and online measurement of the geometries of train wheelsets: A review.
– IEEE Transactions on Instrumentation and Measurement, 2022

 

Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Book of Award

Prof. Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Guangzhou Medical University | China

Prof. Lingmin Zhang is a leading researcher whose work integrates pharmaceutics, biomedical materials, and gene delivery, contributing significantly to advanced therapeutic strategies, particularly in lung cancer and inflammatory diseases. With 3,077 citations , 79 publications, and an h-index of 27, the researcher's scholarly impact is widely recognized. The work focuses on innovative nano-based and biomimetic delivery platforms, including nano-PROTACs, exosomes, microfluidic nanovesicles, and CRISPR/Cas9 carriers, offering transformative possibilities for targeted and precision medicine. Supported by major grants from the National Natural Science Foundation of China (projects 82572415, 82072047, 81700382), the researcher has developed cutting-edge strategies such as reprogramming tumor-associated macrophages, overcoming drug resistance in lung cancer, and reversing epigenetic silencing through nanoparticle-mediated gene delivery. Influential publications in high-impact journals—including Journal of Controlled Release, Drug Resistance Updates, ACS Nano, Angewandte Chemie, Advanced Science, and Molecular Cancer—highlight breakthroughs in nano-therapeutics, PROTAC technologies, artificial exosomes, and nucleic-acid delivery systems. Collectively, these contributions position the researcher at the forefront of translational nanomedicine, with ongoing work offering new directions for precision oncology, regenerative strategies, and next-generation drug delivery platforms.

Profile : Scopus | Orcid

Featured Publication

He, M., Peng, Q., Yang, Q., Guan, X., Liu, Q., Chen, R., Zhou, D., Wang, L., Zhang, Y., Li, S., Su, J., & Zhang, L. (2026). In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy. Journal of Controlled Release, 2026, 114497.

Zhang, L., He, L., Lin, Y., Wei, J., Tang, S., Lei, X., Lin, X., Zhou, D., Fu, L., Li, Y., He, J., Liang, L., & Yu, X. (2026). The novel strategy to overcome drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells. Drug Resistance Updates, 84, 101316.

Chen, S., Chen, E., Su, J., Gong, Y., Tang, S., Qin, A., Shen, A., Tang, S., & Zhang, L. (2025). Magnetically navigated nano-PROTAC ameliorates acute lung injury. Journal of Nanobiotechnology, 23, 622.

Li, X., Qin, Z., Wang, S., Zhang, L., & Jiang, X. (2025). Microfluidics-assembled nanovesicles for nucleic acid delivery. Accounts of Chemical Research, 58, 570–582.

Liang, L., Peng, W., Qin, A., Zhang, J., Chen, R., Zhou, D., Zhang, X., Zhou, N., Yu, X., & Zhang, L. (2024). Intracellularly synthesized artificial exosome treats acute lung injury. ACS Nano, 18(32), 21009–21023.

Guan, X., Xu, X., Tao, Y., Deng, X., He, L., Lin, Z., Chang, J., Huang, J., Zhou, D., Yu, X., Wei, M., & Zhang, L. (2024). Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy. Journal of Nanobiotechnology, 22, 692.

Zhang, L., Lin, Y., Li, S., Guan, X., & Jiang, X. (2023). In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes. Angewandte Chemie International Edition, 62(11), e202217089.

Liang, L., Cen, H., Huang, J., Qin, A., Xu, W., Wang, S., Chen, Z., Tan, L., Zhang, Q., Yu, X., Yang, X., & Zhang, L. (2022). The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Molecular Cancer, 21(1), 186.

Zhang, H., Peng, R., Chen, S., Shen, A., Zhao, L., Tang, W., Wang, X., Li, Z., Zha, Z., Yi, M., & Zhang, L. (2022). Versatile nano-PROTAC-induced epigenetic reader degradation for efficient lung cancer therapy. Advanced Science, 9(29), 2202039.

Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019). Triple-targeting delivery of CRISPR/Cas9 to reduce the risk of cardiovascular diseases. Angewandte Chemie International Edition, 58(36), 12404–12408.

Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Insubria | Italy

Dr. Annalisa Bosi is a distinguished researcher with 909 citations, 29 scientific documents, and an h-index of 15, reflecting her strong impact in the fields of immunology, gastrointestinal pathology, and microbiota–gut–brain axis research. Her early work focused on the phenotypic and functional characterization of innate immune components, particularly NK cells and macrophages, examining their role in tumor pathogenesis and their modulation by chemotherapeutic agents or plant-derived molecules. She later advanced her research to explore molecular and cellular mechanisms underlying major gastrointestinal diseases such as ischemia, intestinal inflammation, and enteric neuropathy, identifying the regulatory role of hyaluronic acid homeostasis in tissue repair. Her recent studies investigate gut microbiota, dysbiosis, and their influence on neurodevelopment and tumor etiopathogenesis, with growing emphasis on prebiotic and probiotic interventions. Dr. Bosi has contributed significantly to understanding experimental models of gut pathology, neuromuscular dysfunction, immunomodulation by virome components, and sex-dependent microbial effects. Her publications span high-impact journals, covering topics such as microbiota–immune interactions, ischemia–reperfusion injury, cytokine–phage crosstalk, and neuroimmune modulation. Through multidisciplinary approaches integrating molecular biology, immunology, and neurogastroenterology, her work continues to shape emerging perspectives on host–microbiota communication and its relevance to disease mechanisms and therapeutic strategies.

Profiles : Scopus | Orcid

Featured Publications

Bosi, A., Baranzini, N., Ponti, A., Moretto, P., Moro, E., Crema, F., Cianci, R., Karousou, E., Viola, M., Passi, A., et al. (2025). Intestinal ischemia/reperfusion injury influences hyaluronan homeostasis in the rat brain. International Journal of Molecular Sciences, 26(20), 10064.

Cianci, R., Caldarelli, M., Brani, P., Bosi, A., Ponti, A., Giaroni, C., & Baj, A. (2025). Cytokines meet phages: A revolutionary pathway to modulating immunity and microbial balance. Biomedicines, 13(5), 1202.

Faggin, S., Cerantola, S., Caputi, V., Tietto, A., Stocco, E., Bosi, A., Ponti, A., Bertazzo, A., Macchi, V., Porzionato, A., et al. (2025). Toll-like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5-hydroxytryptaminergic neurotransmission. British Journal of Pharmacology, 182(8), 1803–1822.

Brani, P., Manzoor, H. Z., Spezia, P. G., Vigezzi, A., Ietto, G., Dalla Gasperina, D., Minosse, C., Bosi, A., Giaroni, C., Carcano, G., et al. (2025). Torque Teno Virus: Lights and shades. Viruses, 17(3), 334.

Dal Lago, S., Brani, P., Ietto, G., Dalla Gasperina, D., Gianfagna, F., Giaroni, C., Bosi, A., Drago Ferrante, F., Genoni, A., Manzoor, H. Z., et al. (2024). Torque Teno Virus: A promising biomarker in kidney transplant recipients. International Journal of Molecular Sciences, 25(14), 7744.

Giambra, V., Pagliari, D., Rio, P., Totti, B., Di Nunzio, C., Bosi, A., Giaroni, C., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023). Gut microbiota, inflammatory bowel disease, and cancer: The role of guardians of innate immunity. Cells, 12(22), 2654.

Bosi, A., Banfi, D., Bistoletti, M., Catizzone, L. M., Chiaravalli, A. M., Moretto, P., Moro, E., Karousou, E., Viola, M., Giron, M. C., et al. (2022). Hyaluronan regulates neuronal and immune function in the rat small intestine and colonic microbiota after ischemic/reperfusion injury. Cells, 11(21), 3370.

Bosi, A., Banfi, D., Bistoletti, M., Moretto, P., Moro, E., Crema, F., Maggi, F., Karousou, E., Viola, M., Passi, A., et al. (2021). Hyaluronan: A neuroimmune modulator in the microbiota–gut axis. Cells, 11(1), 126.

Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021). Dopamine transporter genetic reduction induces morpho-functional changes in the enteric nervous system. Biomedicines, 9(5), 465.

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021). Impact of microbial metabolites on microbiota–gut–brain axis in inflammatory bowel disease. International Journal of Molecular Sciences, 22(4), 1623.

Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020). Innate immunity effector cells as inflammatory drivers of cardiac fibrosis. International Journal of Molecular Sciences, 21(19), 7165.

Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A., Bruno, A., & Mortara, L. (2020). The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors. International Journal of Molecular Sciences, 21(9), 3125.

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020). Tryptophan metabolites along the microbiota–gut–brain axis: An interkingdom communication system influencing the gut in health and disease. International Journal of Tryptophan Research, 13, 1–18.

Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Humanitas Consortium University - ARTOI Foundation | Italy

Prof. Dr. Massimo Bonucci is a distinguished researcher whose scholarly contributions span integrative oncology, cancer therapeutics, and complementary medical approaches. With 153 citations from 153 documents, 20 published documents, and an h-index of 8, his scientific work reflects a growing influence in evidence-based integrative cancer research. His publications demonstrate a strong focus on combining conventional oncology with complementary modalities to enhance patient outcomes, as seen in studies addressing glioblastoma survival, integrative management of myeloproliferative neoplasms, and the synergistic effects of natural compounds such as curcumin, polydatin, and epigallocatechin gallate. His research portfolio includes influential articles in journals such as Journal of Clinical Medicine, Cancers, Onco, Journal of Integrative and Complementary Medicine, and the International Journal of Integrative Oncology, covering topics from locoregional hyperthermia to hematologic diseases, qualitative patient-care insights, and global initiatives in integrative oncology. Recent works explore advancements in dietary supplements, hyperthermia applications, patient-centered care strategies, and international collaborations within the integrative oncology community. Through his continuous contributions and multidisciplinary perspective, Prof. Dr. Bonucci has helped expand the scientific foundation of integrative oncology, supporting its development as a complementary framework within modern cancer research.

Profiles : Scopus | Orcid

Featured Publications

Andreazzoli, F., Yurkovski, I. L., Gowin, K., & Bonucci, M. (2025). Management of myeloproliferative neoplasms: An integrative approach. Journal of Clinical Medicine.

Bonucci, M., Fuggetta, M. P., Anelli, L., Giannarelli, D., Fiorentini, C., & Ravagnan, G. (2025). New approach for enhancing survival in glioblastoma patients: A longitudinal pilot study on integrative oncology. Cancers.

Fiorentini, G., Sarti, D., Mambrini, A., Mattioli, G., Bonucci, M., Ginocchi, L., Cristina, G., Ranieri, G., Bonanno, S., Milandri, C., et al. (2025). Locoregional hyperthermia in cancer treatment: A narrative review with updates and perspectives. Onco.

Bonucci, M. (2025). Superior oral bioavailability of epigallocatechin gallate from TèPigal 300®, a dietary supplement versus a cup of green tea. Journal of Clinical Medical Research.

Stylianou, K., Fuller-Shavel, N., Ghelman, R., Ben-Arye, E., Bonucci, M., Jia, L., Narayanan, S., & Rao, S. (2025). Bridging borders in integrative oncology: A global initiative by the Society for Integrative Oncology. Journal of Integrative and Complementary Medicine.

Bonucci, M. (2025). Introduction to hematologic diseases and integrative therapies: The use of natural supplements and complementary therapies with clinical and preclinical evidence. Figshare.

Chiarlone, P. (2024). Words are life: Written memories in the hospice experience—A qualitative study. International Journal of Integrative Oncology.

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The synergistic combination of curcumin and polydatin improves temozolomide efficacy on glioblastoma cells. International Journal of Molecular Sciences.

Mazzotti, E. (2024). Physical activity in the treatment of cancer patients: An online survey for Italian oncologists and radiotherapists. International Journal of Integrative Oncology.

Mazzotti, E. (2024). Letter to editor on: A feasibility study for the acceptability of virtual reality for patients with cancer undergoing treatment. International Journal of Integrative Oncology.

Cracolici, F. (2024). Improving the quality of life of breast cancer patients with integrated medicine techniques. International Journal of Integrative Oncology.

Anelli, L. (2024). Case report of possible abscopal effect in a patient with metastatic bladder cancer treated with radiotherapy and Artemisia compounds. International Journal of Integrative Oncology.

Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

IRCCS Synlab SDN | Italy

Dr. Giovanni Smaldone is a highly accomplished researcher whose work spans molecular biology, structural biochemistry, oncology, immunology, and advanced diagnostic technologies. With 1,037 citations, 83 published works, and an h-index of 18, his contributions reflect both productivity and strong scientific impact. His research integrates structural biology, NMR spectroscopy, molecular interactions, and translational oncology, with a particular emphasis on childhood acute lymphoblastic leukemia (ALL). He has led and contributed to numerous funded research projects, including competitive grants focused on long non-coding RNAs, epigenetic markers, and the KCTD protein family in pediatric leukemia. His studies also extend into protein delivery systems, nanogels, cellular imaging, and biobank development for rare pediatric disorders. Dr. Smaldone’s recent publications highlight advancements in 3D refractive index tomography for leukemia cell analysis, targeted drug-delivery platforms, diagnostic biomarkers such as circular RNAs and LINC00958, and the structural mechanisms underlying KCTD–Cullin 3 interactions. His work frequently appears in high-impact journals across molecular sciences, biomedical engineering, nanotechnology, and clinical research. Additionally, he has presented widely at national and international scientific conferences, contributing to knowledge dissemination in cellular biophysics, protein structure, pediatric oncology, and advanced molecular diagnostics.

Profiles : Scopus | Orcid

Featured Publications

Bianco, V., Pirone, D., Schiavo, M., Bianco, V., Miccio, L., Memmolo, P., Smaldone, G., Pecoraro, G., Altieri, F., Salvatore, M., et al. (2026). Quantitative mapping of leukemia cells and intracellular lipid droplets using 3D refractive index tomography in flow cytometry. IEEE Journal of Selected Topics in Quantum Electronics.

Pizzella, M., Accardo, A., Mercurio, F. A., Sibillano, T., Gallo, E., Morelli, G., Smaldone, G., Giannini, C., Leone, M., Balasco, N., et al. (2025). Structural and functional characterization of self-assembling fragments identified from the transthyretin amyloid-like structure. Nanoscale.

Leone, I., Costabile, V., Smaldone, G., Franzese, M., Soricelli, A., & D’Agostino, A. (2025). Arthrospira platensis attenuates endothelial inflammation and monocyte activation. International Journal of Molecular Sciences.

Gallo, E., Smaldone, G., Cimmino, L., Braile, M., Orlandella, F. M., Luciano, N., Accardo, A., & Salvatore, G. (2025). Fmoc-FF nanogel-mediated delivery of doxorubicin and curcumin in thyroid cancer cells. Pharmaceutics.

Balasco, N., Esposito, L., Smaldone, G., Salvatore, M., & Vitagliano, L. (2024). A comprehensive analysis of the structural recognition between KCTD proteins and Cullin 3. International Journal of Molecular Sciences.

Bianco, V., Wang, Z., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., Mossetti, G., Maffettone, P. L., Salvatore, M., & Ferraro, P. (2024). Adaptive space-time digital holography for imaging flow cytometry and tissue slide analysis. In Digital Holography and Three-Dimensional Imaging (DH 2024).

Coppola, L., Grimaldi, A. M., Sarnacchiaro, G., Di Fasano, M. S., Smaldone, G., & Salvatore, M. (2024). An overview of Synlab SDN Biobank’s quality control system. Scientific Reports.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Biobank for craniosynostosis and faciocraniosynostosis: A study protocol. Child’s Nervous System.

Bianco, V., Valentino, M., Pirone, D., Miccio, L., Memmolo, P., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., & Mossetti, G. (2024). Classifying breast cancer and fibroadenoma tissue biopsies using fractal biomarkers in Fourier ptychographic microscopy. Computational and Structural Biotechnology Journal.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Correction: Biobank for craniosynostosis and faciocraniosynostosis. Child’s Nervous System.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Scientific Reports.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Research Square.

Filomena, A., Smaldone, G., Ginevra, S., Santiago, N., Di Fasano, M. S., Peppino, M., Alessandra, C., Antonia, D. M., Giuliana, B., Rosanna, P., et al. (2024). Identification of a circular RNA isoform of WASHC2A as a prognostic factor for high-risk pediatric B-ALL. Biomedicine & Pharmacotherapy.

Raymundo, J. R., Zhang, H., Smaldone, G., Zhu, W., Daly, K. E., Glennon, B. J., Pecoraro, G., Salvatore, M., Devine, W. A., Lo, C. W., et al. (2024). KCTD1/KCTD15 complexes control ectodermal and neural crest cell functions. Journal of Clinical Investigation.

Altieri, F., Buono, L., Lanzilli, M., Mirabelli, P., Cianflone, A., Beneduce, G., De Matteo, A., Parasole, R., Salvatore, M., & Smaldone, G. (2024). LINC00958 as a diagnostic and prognostic biomarker of childhood B-cell acute lymphoblastic leukemia. Frontiers in Oncology.

Bingbing Wu | Health Professions | Best Researcher Award

Published on by Book of Award

Dr. Bingbing Wu | Health Professions | Best Researcher Award

Zhejiang University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Bingbing Wu began his academic journey with a strong foundation in biological sciences and technology, later advancing to doctoral studies in animal science at Zhejiang University. His early academic training provided him with a deep understanding of cellular biology, developmental processes, and molecular mechanisms, which later became central to his research in regenerative medicine and women’s health. These formative years not only shaped his scientific curiosity but also set the stage for his future contributions to stem cell biology and tissue regeneration.

Professional Endeavors

Following his doctoral studies, Dr. Wu pursued postdoctoral research at Zhejiang University School of Medicine and The First Affiliated Hospital of Zhejiang University, where he investigated the molecular underpinnings of tissue regeneration and gynecological diseases. His professional path led him to roles as a research assistant, full-time researcher, and later junior principal investigator at Zhejiang University’s International School of Medicine. Each role deepened his expertise in applying cutting-edge technologies to complex medical problems and allowed him to cultivate leadership in research.

Contributions and Research Focus

Dr. Wu’s research is centered on stem cell biology, regenerative medicine, and women’s reproductive health. His work investigates key stem cells involved in endometrial development and regeneration, along with the regulatory mechanisms driving their differentiation. He applies single-cell and spatial multi-omics technologies to unravel the pathological basis of diseases such as intrauterine adhesions and preeclampsia. By integrating organoid models, he has advanced understanding of maternal-fetal interface formation and disease mechanisms, providing novel insights into therapeutic approaches for obstetric and gynecological conditions.

Accolades and Recognition

Throughout his career, Dr. Wu has earned prestigious recognition through numerous competitive research grants. He has been a principal investigator on projects funded by the National Natural Science Foundation of China and the Zhejiang Province Key Projects, reflecting the national and regional confidence in his scientific leadership. His publications in respected international journals such as ACS Applied Materials & Interfaces, Stem Cell Reports, Cell Discovery, and NPJ Regenerative Medicine highlight his contributions to the advancement of regenerative medicine and biomedical science.

Impact and Influence

Dr. Wu’s work has had a significant impact on the field of regenerative medicine, particularly in women’s reproductive health. His studies have not only elucidated molecular pathways of tissue development but also provided translational potential for developing bioactive materials and therapeutic interventions. By combining experimental and computational approaches, he has expanded the scope of regenerative research, inspiring peers and contributing to the global understanding of complex gynecological disorders.

Legacy and Future Contributions

As a scientist committed to innovation, Dr. Wu continues to push the boundaries of regenerative biology. His current projects focus on human adult uterine cell atlases, endometrial tissue engineering, and the role of specific stromal and immune cell populations in tissue regeneration. With ongoing leadership in funded projects and collaborations, he is shaping a scientific legacy that bridges fundamental biology with clinical application. His future contributions are expected to bring new hope for women suffering from reproductive health disorders.

Publications

Article: Autologous platelet-rich plasma dual-network hydrogel promotes human endometrial regeneration
Authors: Xiao Chen, Chengcheng Zhu, Lu Wang, Jialing Deng, Zhuomin Wang, Xiaolin Wu, Haimin Tan, Yiyuan Qu, Bingbing Wu, Yu Li, Keren Cheng, Jian Xu
Journal: Acta Biomaterialia
Year: 2025

Article: Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration
Authors: Cheng Zhang, Chengcheng Zhu, Xiao Chen, Xuzhi Chen, Di Zhang, Huafei Zhao, Junwen Zhang, Yu Zhang, Wanwan Xu, Xiaofeng Zhao, Yingying Hu, Wei Wei, Jian Xu, Yu Li, Bingbing Wu
Journal: Acta Biomaterialia
Year: 2025

Article: Reshaping the chromatin landscape in HUVECs from small-for-gestational-age newborns
Authors: Lingling Yan, Zhimin Zhou, Shengcai Chen, Xin Feng, Junwen Mao, Fang Luo, Jianfang Zhu, Xiuying Chen, Yingying Hu, Yuan Wang, Bingbing Wu, Lizhong Du, Chunlin Wang, Liang Gong, Yanfen Zhu
Journal: JCI Insight
Year: 2025

Article: Size- and Dose-Dependent Body-Wide Organ Transcriptomic Responses to Calcium Phosphate Nanomaterials
Authors: Yu Li, Wei Jiang, Nanfang Nie, Jiaqi Xu, Xiaozhao Wang, Junwen Zhang, Jiahuan Guan, Chengcheng Zhu, Cheng Zhang, Ying Gu, Xiaoyi Chen, Shasha Yao, Zi Yin, Bingbing Wu*, Hongwei Ouyang*, Xiaohui Zou*
Journal: ACS Applied Materials & Interfaces
Year: 2023

Article: A Dual-Crosslinked Hydrogel Based on Gelatin Methacryloyl and Sulfhydrylated Chitosan for Promoting Wound Healing
Authors: Shunxian Ji, Yushuang Zhao, Xinrang Zhai, Lu Wang, Huali Luo, Zhiyong Xu, Wei Dong, Bingbing Wu*, Wei Wei*
Journal: International Journal of Molecular Sciences
Year: 2023

Conclusion

Dr. Bingbing Wu stands as a distinguished researcher whose academic dedication, professional achievements, and scientific contributions have left a lasting mark on regenerative medicine. His focus on stem cells, multi-omics, and endometrial regeneration has advanced both theoretical knowledge and applied therapeutic strategies. With continued research, mentorship, and innovation, he is poised to expand his influence further, leaving a legacy of discovery and practical impact in the field of health professions.

Hui Shen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Prof. Hui Shen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China

Author Profile

Google Scholar

🎓 Early Academic Pursuits

Prof. Hui Shen embarked on his scientific journey with a Bachelor’s degree in Bioengineering from Wuhan University of Science and Technology (2008–2012), laying a strong foundation in the life sciences. He then pursued a Ph.D. in Biochemistry and Molecular Biology at the prestigious University of Science and Technology of China (2012–2017). His doctoral thesis focused on structural biology, specifically analyzing proteins in Saccharomyces cerevisiae and Staphylococcus aureus, under the mentorship of Prof. Maikun Teng.

👨‍🔬 Professional Endeavors

Prof. Shen has steadily ascended the academic ladder. After completing his Ph.D., he undertook postdoctoral research at the University of Pennsylvania’s Perelman School of Medicine (2018–2023). Working in Prof. Kathy Fange Liu's lab, he focused on RNA biology and molecular mechanisms in human cells. In 2023, he returned to China and assumed the role of Professor at China Pharmaceutical University in Nanjing, where he continues to contribute to cutting-edge research in the School of Life Science and Technology.

🧬 Contributions and Research Focus

Prof. Shen's research centers on RNA biology, structural biochemistry, and epigenetic regulation. He has delved into RNA helicases, methyltransferases, and RNA-protein interactions, significantly expanding our understanding of sexually dimorphic RNA metabolism, ribosome assembly, and RNA modifications. His work has elucidated mechanisms of phase separation, methylation, and protein structure-function relationships, all of which are vital for both basic science and therapeutic development.

🏆 Accolades and Recognition

Prof. Shen’s scholarly output is remarkable. He has published over a dozen first-author papers in high-impact journals such as Nature Communications, Molecular Cell, Genes & Development, and Journal of Biological Chemistry. His co-authored works also feature in Science Advances, Nature Communications, and ACS Catalysis, underscoring his collaborative and interdisciplinary impact. His presence in top-tier international conferences, including the RNA Society Annual Meeting and the Global Congress of Chinese Biologists, reflects peer recognition of his contributions.

🌍 Impact and Influence

Prof. Shen’s work has influenced fields such as cancer biology, infectious disease research, and epigenetics. For instance, his studies on the DDX3X/DDX3Y helicases and DIMT1 methyltransferases provide novel insights into cell proliferation, translation regulation, and leukemia biology. His findings are not only academically significant but also open avenues for diagnostic and therapeutic strategies targeting RNA and protein modification pathways.

🔮 Legacy and Future Contributions

As a rising star in molecular biology, Prof. Shen is well-positioned to leave a lasting legacy. With a strong publication track record, international training, and a leadership role in China, he is expected to mentor the next generation of scientists while continuing to pioneer research at the interface of structure and function in RNA biology. His work is likely to shape future innovations in biomedicine and pharmaceutical sciences, strengthening China’s global research footprint.

Publications

  • 📄 Specific catalytically impaired DDX3X mutants form sexually dimorphic hollow condensates
    Authors: Owens MC*, Shen H*, Yanas A, Mendoza-Figueroa MS, Lavorando E, Wei XY, Shweta H, Tang HY, Goldman YE, Liu KF
    Journal: Nature Communications
    Year: 2024

  • 📄 Identification of an RNA-binding region in 18S dimethyladenosine methyltransferase DIMT1 essential for proliferation of acute myeloid leukemia cells
    Authors: Gonskikh Y*, Stoute J*, Shen H*, Budinich K, Pingul B, Schultz K, Marmorstein R, Shi JW, Liu KF
    Journal: Genes & Development
    Year: 2023

  • 📄 Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation
    Authors: Shen H*, Yanas A*, Owens MC, Zhang C, Fritsch C, Fare CM, Copley KE, Shorter J, Goldman YE, Liu KF
    Journal: Molecular Cell
    Year: 2022

  • 📄 Human DIMT1 generates N2⁶,6A-dimethylation-containing small RNAs
    Authors: Shen H, Gonskikh Y, Stoute J, Liu KF
    Journal: Journal of Biological Chemistry
    Year: 2021

  • 📄 TET-mediated 5-methylcytosine oxidation in tRNA promotes translation
    Authors: Shen H*, Ontiveros RJ*, Owens MC, Liu MY, Ghanty U, Kohli RM, Liu KF
    Journal: Journal of Biological Chemistry
    Year: 2021

 

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024